GovWire

Press release: Global AI challenge to investigate veterans’ cardiovascular health launched

Medicines Healthcare Products Regulatory Agency

May 25
15:10 2023

The Veterans Cardiac Health and AI Model Predictions (V-CHAMPs) Challenge, launches today, 25 May 2023, from the VHA Innovation Ecosystem, the FDA Digital Health Center of Excellence, precisionFDA (part of the FDAs Office of Digital Transformation) and the Medicines and Healthcare products Regulatory Agency (MHRA).

Using entirely synthetic datasets based on real US veteran health records, participants will explore a range of potential outcomes following heart failure, including the prediction of cardiovascular outcomes, hospital readmission rates and mortality.

This will help health systems both in the US and the UK to better understand the cardiovascular risks and specific health outcomes in veterans, as well as increasing understanding of synthetic data and AI/ML models and how they could be used to explore similar topics in the future.

In the US, cardiovascular diseases such as heart failure, heart attacks, strokes, and peripheral artery disease are the leading cause of hospitalisation in the Veterans Affairs healthcare system and a major cause of disability impairing the lives of veterans across the United States.

Paul Campbell, interim Head of Software at the MHRA, said:

This is a unique chance for any developer or team to get involved, challenge themselves against other experts across the globe, all while contributing towards a worthy goal.

Having access to hi-fidelity synthetic datasets will be a game-changer in this space, offering an opportunity for participants to test the potential of synthetic data to its limits.

Im so pleased to be able to work with our US partners, bringing together cutting-edge health data expertise from both sides of the Atlantic, and I cant wait to see what the contestants build with this data.

Further information

V-CHAMPs Challenge homepage

Follow us on Twitter: @MHRAgovuk

Follow us on

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: